Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
Sylvain Mathieu,1,2 Marion Couderc,1,2 Baptiste Glace,1,2 Bruno Pereira,2,3 Anne Tournadre,1,2 Jean-Jacques Dubost,1,2 Martin Soubrier1,21Department of Rheumatology, Gabriel-Montpied Hospital, 2Faculty of Medicine, University Clermont 1, 3Délégation de la Recherche Clinique, Ga...
Guardado en:
Autores principales: | Mathieu S, Couderc M, Glace B, Pereira B, Tournadre A, Dubost JJ, Soubrier M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10caf1be94814f1781ec7ff2e9f6d82c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
por: Joseph R Lutt
Publicado: (2009) -
Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Augustine JM, et al.
Publicado: (2012) -
A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations
por: Wells AF, et al.
Publicado: (2014) -
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
por: Benucci M, et al.
Publicado: (2018) -
Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Jasmin B Kuemmerle-Deschner, et al.
Publicado: (2009)